1150 



SUBJECT INDEX 



Cyanocobalamin, 

 analogs of, 



bacterial growth, 589-590 

 cyanocobalamin biosynthesis, 589 

 diol dehydrase, 590 

 methionine biosynthesis, 590 

 biosynthesis of, analogs, 589 



Cyclic - 2', 3'- adenosinemonophosphate, 

 isocitrate dehydrogenase, 509 



Cyclic - 3 ', 5 '- adenosinemonophosphate, 

 phosphofructokinase, 474 



Cyclic-2',3'-guanosinemonopho8phate, 

 deoxycytidylate deaminase, 469 



Cyclobutane- 1 , 1 -dicarboxylate, 

 intercharge distance, 7 

 succinate dehydrogenase, 37, 40 



Cyclohexaneacetate, chymotrypsin, 370 



y-CycIohexanebutyrate, 

 chymotrypsin, 370 



kynurenine:a-ketoglutarate transami- 

 nase, 608-609 



Cyclohexanecarboxylate, 



kynurenine:a-ketoglutarate transami- 

 nase, 608-609 

 tyrosinase, 300-302 



Cyclohexane- 1 ,2-dicarboxylate, 

 intercharge distance, 7 

 kynurenine:a-ketoglutarate transami- 

 nase, 608 

 succinate dehydrogenase, 38, 40 



^-Cyclohexanepropionate, chymotrypsin , 

 369-370 



Cyclohexyl-DL-alanine, phenylalanine hy- 

 droxylase, 354 



Cyclohydrolase, folate analogs, 585 



Cyclopentane-l,2-dicarboxylate, 

 acetate utilization, 241 

 intercharge distance, 7 

 pyruvate utilization, 241 

 succinate dehydrogenase, 37, 40, 241 



D-Cycloserine (orientomycin, Oxamycin), 

 D-alanyl-D-alanine synthetase, 360 

 L-asparagine:a-ketoglutarate transami- 

 nase, 360 

 bacterial growth, 359-360 



antagonism by D-alanine, 359 

 antagonism by alanylalanine, 360 

 cell wall formation, 359 



central nervous system, 359 



GABA : a - ketoglutarate transaminase, 



359 



glutamate decarboxylase, 359 



mycobacterial growth, 359 



oxime formation with pyridoxal-P, 359 



staphylococcal resistance to, 359 



structure of, 359 



transaminases, 359 

 L-Cycloserine, 



L-alanine:a-ketoglutarate transaminase, 



360 



L-asparagine:a-ketoglutarate transami- 

 nase, 360 



bacterial growth, antagonism by L-ala- 



nine, 359 

 Cystamine, glucose utilization in erythro- 

 cytes, 663 

 Cystamine monosulfoxide, 3-phosphogly- 



ceraldehyde dehydrogenase, 663 

 D-Cysteine, L-alanine dehydrogenase, 354 

 L-Cysteine, 



arginase, 337 



homoserine kinase, 357 



serine deaminase, 357 



tyrosine decarboxylase, 307 

 Cysteine desulfurase, 



analogs, 357 



deoxypyridoxol in vivo, 570 



malonate, 60 

 Cystine, 



enzyme inhibitions, 661-664 



oxidation of protein SH groups, 661, 



663 

 Cytidine, 



aspartate carbamyltransferase, 467-468 



5 '-nucleosidase, 472 

 Cytidinediphosphate (CDP), 



aspartate carbamyltransferase, 468 



NADH oxidase, 511 

 Cytidinemonophosphate (CMP), 



adenylosuccinate synthetase, 467 



aspartate carbamyltransferase, 467-468 



deoxycytidylate deaminase, 469 



pyrophosphatase, 475 



ribonuclease, 475 

 Cytidinetriphosphate (CTP), aspartate 



carbamyltransferase, 468 



